News FDA Warning Letter: MedOffice Saglik Endustri Anonim Sirketi 3 November 2024 gmpinsiders he FDA inspection at MedOffice Saglik Endustri Anonim Sirketi revealed significant CGMP violations that could jeopardize product quality and consumer safety. Issues ranged from inadequate testing of drug products to…
Articles QA Corrective and Prevention Action (CAPA) Plan in GMP 14 April 2024 gmpinsiders Explore CAPA's role in GMP for pharmaceuticals: key processes, challenges, and strategies for regulatory compliance
